161 related articles for article (PubMed ID: 35927685)
1. Quality of life improving after propranolol treatment in patients with Infantile Hemangiomas.
Pensabene M; Di Pace MR; Baldanza F; Grasso F; Patti M; Sergio M; La Placa S; Giuffre' M; Serra G; Casuccio A; Cimador M
Ital J Pediatr; 2022 Aug; 48(1):140. PubMed ID: 35927685
[TBL] [Abstract][Full Text] [Related]
2. Parental experiences with propranolol versus oral corticosteroids for complicated infantile hemangioma, a retrospective questionnaire study.
Hermans DJ; Zweegers J; Evers AW; Van Der Vleuten CJ
Eur J Dermatol; 2013; 23(6):857-63. PubMed ID: 24185746
[TBL] [Abstract][Full Text] [Related]
3. Worsening ulceration of infantile hemangioma after initiation or escalation of propranolol.
Meyer-Mueller C; Nicholson C; Polcari I; Boull C; Maguiness S
Pediatr Dermatol; 2022 Mar; 39(2):255-259. PubMed ID: 35178750
[TBL] [Abstract][Full Text] [Related]
4. Treatment of problematic infantile hemangiomas with propranolol: a series of 40 cases and review of the literature.
Oksiuta M; Matuszczak E; Dębek W; Dzienis-Koronkiewicz E; Hermanowicz A; Tylicka M
Postepy Hig Med Dosw (Online); 2014 Sep; 68():1138-44. PubMed ID: 25228522
[TBL] [Abstract][Full Text] [Related]
5. Propranolol therapy of infantile hemangiomas: efficacy, adverse effects, and recurrence.
Xiao Q; Li Q; Zhang B; Yu W
Pediatr Surg Int; 2013 Jun; 29(6):575-81. PubMed ID: 23519547
[TBL] [Abstract][Full Text] [Related]
6. Propranolol treatment in life-threatening airway hemangiomas: a case series and review of literature.
Broeks IJ; Hermans DJ; Dassel AC; van der Vleuten CJ; van Beynum IM
Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1791-800. PubMed ID: 24074695
[TBL] [Abstract][Full Text] [Related]
7. Propranolol for the treatment of infantile hemangiomas: a nine-year monocentric experience from a tertiary hospital.
Volonté M; Codazzi AC; Davidovich S; Apicella A; Isoletta E; Barruscotti S; Massa M; Silvestri A; Marseglia GL; Brazzelli V
Eur J Dermatol; 2023 Jun; 33(3):265-269. PubMed ID: 37594334
[TBL] [Abstract][Full Text] [Related]
8. Oral Nadolol for Children with Infantile Hemangiomas and Sleep Disturbances with Oral Propranolol.
Bernabeu-Wittel J; Narváez-Moreno B; de la Torre-García JM; Fernández-Pineda I; Domínguez-Cruz JJ; Coserría-Sánchez F; Álvarez-del-Vayo C; Conejo-Mir J
Pediatr Dermatol; 2015; 32(6):853-7. PubMed ID: 26447831
[TBL] [Abstract][Full Text] [Related]
9. Atenolol as an alternative to propranolol for the management of sleep disturbances in the treatment of infantile hemangiomas.
Gumina ME; Yan AC
Pediatr Dermatol; 2019 Jul; 36(4):556-557. PubMed ID: 30983047
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of propranolol cream in infantile hemangioma: A prospective pilot study.
Nagata E; Kashiwagura Y; Okada E; Tanaka S; Sano S; Nishida M; Hayano S; Iwashima S; Hakamata A; Odagiri K; Inui N; Watanabe H; Umemura K; Uchida S
J Pharmacol Sci; 2022 Jun; 149(2):60-65. PubMed ID: 35512856
[TBL] [Abstract][Full Text] [Related]
11. Oral propranolol for treating infantile hemangiomas: a case series of 57 patients.
Zegpi-Trueba MS; Abarzúa-Araya A; Silva-Valenzuela S; Navarrete-Dechent C; Uribe-González P; Nicklas-Díaz C
Actas Dermosifiliogr; 2012 Oct; 103(8):708-17. PubMed ID: 22853960
[TBL] [Abstract][Full Text] [Related]
12. Exploration of the optimal time to discontinue propranolol treatment in infantile hemangiomas: A prospective study.
Wang L; Wang W; Zhou Z; Li J; Li Z; Lv R; Xu G; Bi J; Huo R
J Am Acad Dermatol; 2024 Apr; 90(4):783-789. PubMed ID: 38159645
[TBL] [Abstract][Full Text] [Related]
13. Recurrence of infantile hemangiomas treated with propranolol.
Bagazgoitia L; Hernández-Martín Á; Torrelo A
Pediatr Dermatol; 2011; 28(6):658-662. PubMed ID: 22082463
[TBL] [Abstract][Full Text] [Related]
14. Outpatient use of oral propranolol and topical timolol for infantile hemangiomas: survey results and comparison with propranolol consensus statement guidelines.
Kumar MG; Coughlin C; Bayliss SJ
Pediatr Dermatol; 2015; 32(2):171-9. PubMed ID: 25556828
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of cases with infantile hemangioma requiring treatment.
Maraşli H; Acipayam C; Güllü UU; Dinçer S; Dalgiç EF; Karaküçük SN; Yurttutan S
Folia Med (Plovdiv); 2022 Feb; 64(1):67-74. PubMed ID: 35851882
[TBL] [Abstract][Full Text] [Related]
16. Propranolol treatment of infantile hemangiomas: anticipatory guidance for parents and caretakers.
Martin K; Blei F; Chamlin SL; Chiu YE; Frieden IJ; Frommelt PC; Garzon MC; Kwon EK; MacLellan-Tobert S; Mancini AJ; Seefeldt M; Sidbury R; Siegel DH; Drolet BA; Boucek RJ
Pediatr Dermatol; 2013; 30(1):155-9. PubMed ID: 23316721
[TBL] [Abstract][Full Text] [Related]
17. Does treatment with propranolol affect quality of life in infantile hemangioma patients and their parents?
de Wild SR; Moyakine AV; van der Vleuten CJM
Pediatr Dermatol; 2019 Nov; 36(6):958-960. PubMed ID: 31566792
[TBL] [Abstract][Full Text] [Related]
18. Outpatient treatment of infantile hemangiomas with propranolol: a prospective study.
Betlloch-Mas I; Martínez-Miravete MT; Lucas-Costa A; Martin de Lara AI; Selva-Otalaurruchi J
Actas Dermosifiliogr; 2012 Nov; 103(9):806-15. PubMed ID: 22727954
[TBL] [Abstract][Full Text] [Related]
19. Patient Perspectives: Propranolol for infantile hemangiomas.
Pediatr Dermatol; 2016 Sep; 33(5):549-50. PubMed ID: 27595871
[No Abstract] [Full Text] [Related]
20. Treatment with propranolol for infantile hemangiomas: single-center experience.
Turhan AB; Bör Ö; Özdemir ZC
J Cosmet Dermatol; 2016 Sep; 15(3):296-302. PubMed ID: 27061310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
